On the use of quantitative modeling to help understand prostate-specific antigen dynamics and other medical problems.
Swanson
Kristin R
KR
True
Lawrence D
LD
Murray
J D
JD
D019380:Anti-HIV Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000473:pathology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005910:Glioma / Q000473:pathology / Q000503:physiopathology; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D008954:Models, Biological; D009361:Neoplasm Invasiveness / Q000503:physiopathology; D017430:Prostate-Specific Antigen / Q000502:physiology*; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology
D019380:Anti-HIV Agents; D017430:Prostate-Specific Antigen